Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 163 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer				Phase III, Phase II				RPCI-RP-9815 NCI-V99-1527, NCT00003816, RP 98-15
	Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy				Phase III, Phase II				GC P#02.01.001 NCT00469729
	In-Vivo Activated T-Cell Depletion to Prevent GVHD				Phase III, Phase II				0705-20 IUCRO-0196 NCT00594308
	Total-Body Irradiation With Or Without Fludarabine Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer				Phase III				FHCRC-1813.00 5666, NCT00075478
	Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases				Phase III				CBMTG-0601 NCT00438958
	Comparing Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation in Individuals With Hematologic Cancers				Phase III				418 BMTCTN-0201, NCT00075816
	Single Versus Double Umbilical Cord Blood Transplantation in Children With High Risk Leukemia and Myelodysplasia				Phase III				467 BMT CTN 0501, 5 U01 HL69294-05, NCT00412360
	A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)				Phase III				CAMN107A2303 NCT00471497
	Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML				Phase III				3160A4-3000 NCT00574873
	Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies				Phase III				SCT 0307 NCT00619879


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute